VitriVax Revenue and Competitors

Boulder, CO USA

Location

#2416

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • VitriVax's estimated annual revenue is currently $11.9M per year.(i)
  • VitriVax's estimated revenue per employee is $189,444
  • VitriVax's total funding is $9M.

Employee Data

  • VitriVax has 63 Employees.(i)
  • VitriVax grew their employee count by 62% last year.

VitriVax's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Co-FounderReveal Email/Phone
3
Co-FounderReveal Email/Phone
4
Head Particle EngineeringReveal Email/Phone
5
VP OperationsReveal Email/Phone
6
Head Product Research and DevelopmentReveal Email/Phone
7
Chief Technical Officer and Head R&DReveal Email/Phone
8
Associate Director FacilitiesReveal Email/Phone
9
Associate Director and Head Preclinical ResearchReveal Email/Phone
10
R&D Project ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M35483%$25MN/A
#2
$2M1318%N/AN/A
#3
$3.4M2210%N/AN/A
#4
$68M439-3%N/AN/A
#5
$2M1330%N/AN/A
#6
$4M268%N/AN/A
#7
$2.7M35-10%$23.2MN/A
#8
$5.3M3470%N/AN/A
#9
$1.7M11-8%N/AN/A
#10
$3.1M20-17%N/AN/A
Add Company

What Is VitriVax?

VitriVax is commercializing a vaccine formulation platform enabling thermostability, and combined doses with timed release, for virtually any injectable vaccine. Our proprietary technology, created at the University of Colorado in Boulder with the support of over $5M from NIH, NSF and the State of Colorado, and most recently, $2.2M from the Bill and Melinda Gates Foundation, makes human and animal vaccines more effective, more affordable, and more accessible globally.

keywords:N/A

$9M

Total Funding

63

Number of Employees

$11.9M

Revenue (est)

62%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.9M63N/AN/A
#2
$17.3M633%N/A
#3
$18.4M63-2%N/A
#4
$14.2M63-10%N/A
#5
$11.9M6315%N/A